How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

C compiler, LustreC, into a generator of both executable code and associated specification. Model-based design tools are ...

Scammers are using a crafty trick called the "call merging scam" to snatch OTPs and empty bank accounts. The scam works when someone calls you pretending to be a friend or acquaintance and asks to ...

Want to know how the Hogwarts Legacy sorting hat works? The sorting process is one of the most important factors as you start your new life at the Wizarding School of Witchcraft and Wizardry. Fans of ...

In the early 1960s, Mack Fulwyler joined the lab of Marvin Van Dilla at the Los Alamos National Laboratory as an engineer to study the effect of fallout radiation from nuclear weapons testing on ...

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. A merger combines two companies into one.

Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to ...